Status: current, Primitive. Date: 30-Jun 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 25561000168117 | Optiray-160 (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 25571000168111 | Optiray-160 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Optiray-160 | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Optiray-160 (ioversol 339 mg / 1 mL) injection, 50 mL vial (trade product unit of use) | Is a | True | Optiray-160 | Inferred relationship | Some | |
| Optiray-160 339 mg (iodine 160 mg)/mL injection, 10 x 50 mL vials | has TP | True | Optiray-160 | Inferred relationship | Some | |
| Optiray-160 339 mg (iodine 160 mg)/mL injection, 10 x 50 mL vials | has TP | True | Optiray-160 | Inferred relationship | Some |
Reference Sets
FHIR